Redox Active Molecules in Cancer Treatments
The book is a reprint of a Special Issue with the same title published online in the chemical journal Molecules (ISSN 1420-3049) within the section of Medicinal Chemistry. It was edited by academic guest editors from September 2020 to April 2022. In total, it includes eighteen research/review articl...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_98096 | ||
| 005 | 20230307 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230307s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-6730-3 | ||
| 020 | |a 9783036567310 | ||
| 020 | |a 9783036567303 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-6730-3 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a TB |2 bicssc | |
| 072 | 7 | |a TBX |2 bicssc | |
| 100 | 1 | |a Stepanić, Višnja |4 edt | |
| 700 | 1 | |a Kučerová-Chlupáčová, Marta |4 edt | |
| 700 | 1 | |a Stepanić, Višnja |4 oth | |
| 700 | 1 | |a Kučerová-Chlupáčová, Marta |4 oth | |
| 245 | 1 | 0 | |a Redox Active Molecules in Cancer Treatments |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (298 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a The book is a reprint of a Special Issue with the same title published online in the chemical journal Molecules (ISSN 1420-3049) within the section of Medicinal Chemistry. It was edited by academic guest editors from September 2020 to April 2022. In total, it includes eighteen research/review articles including the editorial. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Technology: general issues |2 bicssc | |
| 650 | 7 | |a History of engineering & technology |2 bicssc | |
| 653 | |a oxygen detection | ||
| 653 | |a dendrogram analysis | ||
| 653 | |a hierarchical clustering | ||
| 653 | |a cancer cells | ||
| 653 | |a luminescence lifetime | ||
| 653 | |a hydrogen peroxide | ||
| 653 | |a oxidative stress | ||
| 653 | |a photodynamic therapy | ||
| 653 | |a time-resolved imaging | ||
| 653 | |a breast cancer | ||
| 653 | |a NRF2 | ||
| 653 | |a polyphenols | ||
| 653 | |a melatonin | ||
| 653 | |a acute myeloid leukemia (AML) | ||
| 653 | |a metformin | ||
| 653 | |a MCL-1 inhibitor S63845 | ||
| 653 | |a reactive oxygen species (ROS) | ||
| 653 | |a AQP3 | ||
| 653 | |a AQP5 | ||
| 653 | |a Anneslea fragrans | ||
| 653 | |a antioxidant | ||
| 653 | |a guided isolation | ||
| 653 | |a flavonoid glycosides | ||
| 653 | |a spheroids | ||
| 653 | |a HT29 cells | ||
| 653 | |a cluster analysis | ||
| 653 | |a principal component analysis | ||
| 653 | |a hydrolysable tannins | ||
| 653 | |a HHDP-digalloylglucose isomer | ||
| 653 | |a dihydroxyphenyl-γ-valerolactone | ||
| 653 | |a autophagy | ||
| 653 | |a colorectal cancer cells | ||
| 653 | |a reactive oxygen species | ||
| 653 | |a endoplasmic reticulum stress | ||
| 653 | |a pentoxifylline | ||
| 653 | |a astaxanthin | ||
| 653 | |a particle encapsulation | ||
| 653 | |a ionizing radiations | ||
| 653 | |a macrophages | ||
| 653 | |a radiation-induced fibrosis | ||
| 653 | |a Rhopilema nomadica | ||
| 653 | |a apoptosis | ||
| 653 | |a cell cycle arrest | ||
| 653 | |a HepG2 | ||
| 653 | |a soybean | ||
| 653 | |a peptides | ||
| 653 | |a antioxidant capacity | ||
| 653 | |a magnetite nanoparticles | ||
| 653 | |a conjugation | ||
| 653 | |a multicomponent reaction | ||
| 653 | |a copper complexes | ||
| 653 | |a glutathione depletion | ||
| 653 | |a cysteine | ||
| 653 | |a Casiopeina | ||
| 653 | |a intermediate | ||
| 653 | |a copper reduction | ||
| 653 | |a papaverine | ||
| 653 | |a cancer | ||
| 653 | |a morphology | ||
| 653 | |a proliferation | ||
| 653 | |a cell cycle | ||
| 653 | |a chain-transfer agent | ||
| 653 | |a chemotherapy | ||
| 653 | |a free radical chain reaction | ||
| 653 | |a lipid peroxidation | ||
| 653 | |a lipophilic thiol | ||
| 653 | |a oxidative cell death | ||
| 653 | |a prooxidative drug | ||
| 653 | |a radical propagation | ||
| 653 | |a rate-limiting step | ||
| 653 | |a mitochondria | ||
| 653 | |a bioenergetics | ||
| 653 | |a anticancer | ||
| 653 | |a cheminformatics | ||
| 653 | |a in silico | ||
| 653 | |a Keap1 | ||
| 653 | |a molecular docking | ||
| 653 | |a molecular dynamics | ||
| 653 | |a myeloperoxidase | ||
| 653 | |a NADPH oxidase | ||
| 653 | |a seed antioxidant peptide | ||
| 653 | |a xanthine oxidase | ||
| 653 | |a osteosarcoma | ||
| 653 | |a naringenin | ||
| 653 | |a ROS | ||
| 653 | |a ER stress | ||
| 653 | |a ferroptosis | ||
| 653 | |a inducers | ||
| 653 | |a inhibitors | ||
| 653 | |a drug-likeness | ||
| 653 | |a neurodegenerative | ||
| 653 | |a polyphenol | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/6868 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/98096 |7 0 |z DOAB: description of the publication |